Back to Aurora® or All Oil Concentrates

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This page was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Dosing Look-Up Table (Estimated)

0.01/g1.25/mg THC1.25/mg CBD
0.05/g6.25/mg THC6.25/mg CBD
0.1/g12.5/mg THC12.5/mg CBD
0.15/g18.75/mg THC18.75/mg CBD
0.2/g25/mg THC25/mg CBD
0.25/g31.25/mg THC31.25/mg CBD
0.3/g37.5/mg THC37.5/mg CBD
/gCalculate THCCalculate CBD

Please note values above are based on registered THC/CBD percentages, subject to ±10% allowed variance. Values provided are 'best case', losses to air during vaporisation or combustion will always occur.

Medication Details

Brand
Canada Aurora®
Designation
T12:C12
Chemotype
Type II: THC/CBD Mix
Carrier Oil
Medium-Chain Triglycerides
THC Potential Range (±10%)
11.25-13.75mg/ml
CBD Potential Range (±10%)
11.25-13.75mg/ml
Cultivated or Packaged in
Flag of Denmark Denmark
Imported by
United Kingdom IPS Pharma
Imported as
Schedule I: Raw Material
Formulated by
United Kingdom IPS Pharma

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: Discontinued

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

Main Partner Pharmacy

Pharmacy Distributor

Dispensing Patient Pharmacies

Grow Access Project

Available on GAP, an access scheme for veterans and recipients of means-tested benefits:

Participating Pharmacy:Pharmacy Price-Matching Unofficially:
Product Description Video Reviews3 Patient Reviews

This oil is derived from Pedanios T20 L.A. Confidential and Aurora C12 Cannatonic.

Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).

Canada About Aurora Europe GmbH

Aurora® Logo

Aurora Cannabis is a leading integrated cannabis company with a robust network of subsidiaries and strategic partnerships. With state-of-the-art production facilities and exclusive sales agreements in the European Union and beyond.

Aurora Cannabis is a leading integrated cannabis company with a robust network of subsidiaries and strategic partnerships. With state-of-the-art production facilities and exclusive sales agreements in the European Union and beyond, Aurora operates around the globe pursuing new and emerging cannabis markets. Through the Company’s unparalleled pace of execution and commitment to innovation, Aurora has become one of the world’s largest and fastest growing cannabis companies that continues to elevate and challenge industry standards.

Aurora has three operational facilities in Canada (Aurora Sky, Aurora Vie, and Aurora Mountain) plus two new facilities projected to be operational by the end of 2019, including a 1,000,000-square-foot (93,000 m2) facility under construction in Odense, Denmark. Construction on the Nordic 2 project in Denmark was stopped in November 2019 when the company's stock dropped to a two year low. The Aurora Sun project in Alberta was put on a temporary hold. These decisions would lead to a savings of $190 million.

Aurora Mountain was Aurora's first facility, completed in 2015. It is a 55,200-square-foot (5,130 m2) production facility in Mountain View County. Aurora Vie is a 40,000-square-foot (3,700 m2), fully licensed, indoor production facility in Pointe-Claire, Quebec. It was the second licensed producer in Quebec, and was acquired in 2017 for $7 million when it was about 80% complete. In 2017, Aurora Cannabis began construction of an automated 800,000-square-foot (74,000 m2) plant in Alberta that it said would be capable of producing 100,000 kilograms of cannabis annually. The land is part of the acreage owned by the Edmonton International Airport. In 2021, Aurora shuttered its Aurora Polaris facility in Edmonton.

  Information provided is partially community sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)